Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Lutronic receives US FDA for eCO2 fractional laser system

Lutronic : 14 July, 2008  (New Product)
Lutronic has received regulatory clearance from the US FDA for the eCO2 system which is a next-generation fractional CO2 laser designed to offer a safe and innovative way to treat deep ablative indications such as resurfacing and coagulation of soft tissue, textural irregularities, fine lines, pigmented lesions, vascular dyschromia, and rhytides.
Using the proprietary Controlled Chaos Technology (CCT), the eCO2 has several features that offer customisable treatments that are easy to use and less painful to the patients.

Dr J David Holcomb, immediate past president of the Florida Society of Facial Plastic Surgeons, stated that 'the eCO2 is a familiar wavelength in an extremely elegant and versatile package, with the ability to perform incisional surgery, traditional ablative resurfacing and ablative microfractional photothermolysis.'

Of particular interest to users is the ability to combine two operational modes in one delivery system, which is important when deep penetration and greater patient comfort is required. With both Static and Dynamic operation modes, users have the capability to stamp up to a 14x14mm scan area as well as the option to ‘feather’ the treatment area to reduce the ‘checkerboard’ appearance that is common with currently available fractional CO2 devices.

Further, at a 120 micron spot size, initial biopsy studies indicate that the laser can penetrate as deep as 2.4mm into the dermis. 'We are seeing long-lasting and consistent results after just one treatment with the eCO2 system. Preliminary results show that patients may not need a follow-up treatment,' said Jhung Won Hwang, PhD, Sr director, regulatory affairs, Lutronic.

With several international and US patents pending, the eCO2 has added multifunctional features, including intuitive software that can select between a random or sequential beam pattern, as well as a built-in skin sensor technology that prevents the laser from firing unless the handpiece tip is in contact with the skin. A wide range of indications may be treated with its three different treatment tip sizes, including a point beam tip for traditional CO2 excision and vapourisation of tissue-tags and pigmented lesions.

Dr Holcomb continued, 'With the safety of the eCO2 micro-fractional laser, optimisation of treatment protocols for off-face skin tightening and rejuvenation will be an area of intense interest.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo